Ocera Announces Top-line Results for Phase 2b Study in Hepatic Encephalopathy
Jan 30, 2017 12:00 pm UTC| Business
Primary and Secondary Endpoints Showed Trend and Dose-Related Clinical Benefit Although Not Statistically Significant Ammonia Scavenger OCR-002 Demonstrated Statistically Significant Reduction in Ammonia Levels OCR-002...
FibroGen’s Roxadustat (FG-4592) Meets Primary Endpoints in Two Phase 3 Anemia Studies in China
Jan 30, 2017 12:00 pm UTC| Business
SAN FRANCISCO, Jan. 30, 2017 -- FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, and its subsidiary FibroGen China Medical Technology Development Co., Ltd. (FibroGen China), today reported...
MGX Minerals Appoints Marc Bruner as Chairman and Head of US Acquisitions of Petro Lithium
Jan 30, 2017 12:00 pm UTC| Business
VANCOUVER, British Columbia, Jan. 30, 2017 -- MGX Minerals Inc. (“MGX” or the “Company”) (CSE:XMG)(FKT:1MG)(OTC:MGXMF) is pleased to announce that Mr. Marc Bruner, a leader in the development of unconventional oil and...
Jan 30, 2017 12:00 pm UTC| Business
HONG KONG, Jan. 30, 2017 -- The Guanghui Technology Group (GTG) and Quantum Materials Asia Co., Ltd., (QMA), a joint venture of GTG and Quantum Materials Corp (OTCQB:QTMM), today reported an investment by the China...
Jan 30, 2017 12:00 pm UTC| Business
Studies to be Administered by Recognized Experts in the Field of Hydrocephalus Company Expects the Studies to be Completed in 2018 HINGHAM, Mass., Jan. 30, 2017 -- Microbot Medical Inc. (Nasdaq:MBOT), a medical...
Jan 30, 2017 12:00 pm UTC| Business
EDISON, N.J., Jan. 30, 2017 -- TechDemocracy, LLC, a global cyber risk assurance solutions provider, today announced the availability of the Intellicta platform to help boards of directors and senior management teams...
Supernus Announces Issuance of Seventh U.S. Patent Protecting Trokendi XR®
Jan 30, 2017 12:00 pm UTC| Business
ROCKVILLE, Md., Jan. 30, 2017 -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases,...